# Calcium Electroporation for Head and Neck Cancer

> **NCT03051269** · PHASE1 · UNKNOWN · sponsor: **Rigshospitalet, Denmark** · enrollment: 6 (estimated)

## Conditions studied

- Head Neck Cancer

## Interventions

- **DRUG:** Calcium chloride
- **DEVICE:** Electroporation

## Key facts

- **NCT ID:** NCT03051269
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2018-12
- **Final completion:** 2019-02
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2017-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03051269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03051269, "Calcium Electroporation for Head and Neck Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03051269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*